Opiant Pharmaceuticals, Inc. (OPNT)
USD 20.65
(0.0%)
USD 20.65
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.92 Million | -2.02 Million | 4.06 Million | -522.97 Thousand | 5.55 Million | -915.28 Thousand |
| Net Income | 3 Million | -1.86 Million | 11.59 Million | -21.19 Million | 6.58 Million | -7.81 Million |
| Depreciation & Amortization | 661.53 Thousand | 608.47 Thousand | 237.78 Thousand | 2556.00 | 5140.00 | 2389.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.74 Million | 2.27 Million | 3.19 Million | - | - | - |
| Change in working capital | -4.76 Million | -3.07 Million | -10.94 Million | 14.12 Million | -2.72 Million | -4.76 Million |
| Other non-cash items | 267.95 Thousand | 16.48 Thousand | -16.5 Thousand | 782.23 Thousand | 190.42 Thousand | 1.35 Million |
| Investing Cash Flow | -15.01 Million | -50.88 Thousand | -302.47 Thousand | - | - | -7537.00 |
| Investments in PPE | - | -50.88 Thousand | -302.47 Thousand | - | - | -7537.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -15.01 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.71 Million | 19.36 Million | 2.6 Million | 17.02 Million | -165 Thousand | 1.97 Million |
| Debt repayment | - | - | - | - | -165 Thousand | -281.19 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 20 Thousand | - | - | 17.15 Million | 190.42 Thousand | 1.18 Million |
| Other Financing Activities | 2.69 Million | 19.36 Million | 2.6 Million | -132.41 Thousand | -190.42 Thousand | 1.06 Million |
| Accounts receivables | -4.41 Million | -1.69 Million | -2.72 Million | 7.2 Million | -3.43 Million | -312.49 Thousand |
| Accounts payables | 308.13 Thousand | 1.63 Million | 361.22 Thousand | -1.92 Million | 2.07 Million | -174.87 Thousand |
| Inventory | -313.69 Thousand | -2.45 Million | -8.28 Million | 8.52 Million | -1.32 Million | 522.92 Thousand |
| Other working capital | -338.13 Thousand | -563.51 Thousand | -293.87 Thousand | 317.64 Thousand | -39.85 Thousand | -4.8 Million |
| Cash at beginning of period | 48.25 Million | 30.98 Million | 24.61 Million | 8.11 Million | 1.48 Million | 434.21 Thousand |
| Cash at end of period | 37.85 Million | 48.25 Million | 30.98 Million | 24.61 Million | 6.87 Million | 1.48 Million |
| Capital Expenditure | - | -50.88 Thousand | -302.47 Thousand | - | - | -7537.00 |
| Effect of forex changes on cash | -28.06 Thousand | -18.63 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -10.39 Million | 17.27 Million | 6.36 Million | 16.49 Million | 5.39 Million | 1.04 Million |
| Free Cash Flow | 1.92 Million | -2.07 Million | 3.76 Million | -522.97 Thousand | 5.55 Million | -922.82 Thousand |
| Breakdown | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 FY | 2021 Q4 | 2021 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.91 Million | -11.73 Million | -12.18 Million | 3 Million | 752.33 Thousand | 3.41 Million |
| Depreciation & Amortization | 12 Thousand | 8110.00 | 7897.00 | 661.53 Thousand | 582.83 Thousand | 15.75 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 424.68 Thousand | 2.09 Million | 2.07 Million | 2.74 Million | - | - |
| Change in working capital | 4.46 Million | -1.14 Million | 7.84 Million | -4.76 Million | 340.42 Thousand | -4 Million |
| Other non-cash items | 277.35 Thousand | 153.48 Thousand | 157.12 Thousand | 267.95 Thousand | -325.81 Thousand | 167.15 Thousand |
| Investing Cash Flow | -411.08 Thousand | 2.49 Million | 12.51 Million | -15.01 Million | 30 Thousand | 27.57 Thousand |
| Investments in PPE | -411.08 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | 12.51 Billion | -15.01 Million | 30 Thousand | 27.57 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 2.49 Million | -12.5 Billion | - | - | - |
| Financing Cash Flow | 402.61 Thousand | 135.67 Thousand | 97.45 Thousand | 2.71 Million | 556.88 Thousand | 1.54 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 402.61 Thousand | - | 2.57 Billion | 20 Thousand | 20 Thousand | - |
| Other Financing Activities | - | 135.67 Thousand | -2.57 Billion | 2.69 Million | 536.88 Thousand | 1.54 Million |
| Accounts receivables | 2.29 Million | 2.11 Million | 8.87 Million | -4.41 Million | 2.09 Million | -5.7 Million |
| Accounts payables | 49.83 Thousand | -2.32 Million | 2.07 Million | 308.13 Thousand | 789.59 Thousand | 149.61 Thousand |
| Inventory | - | - | - | -313.69 Thousand | - | - |
| Other working capital | 2.11 Million | -940.21 Thousand | -3.1 Million | -338.13 Thousand | -2.54 Million | 1.54 Million |
| Cash at beginning of period | 40.17 Million | 48.32 Million | 37.85 Million | 48.25 Million | 35.28 Million | 33.44 Million |
| Cash at end of period | 35.37 Million | 40.17 Million | 48.32 Million | 37.85 Million | 37.85 Million | 35.28 Million |
| Capital Expenditure | -411.08 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | -48.75 Thousand | -154.62 Thousand | -37.36 Thousand | -28.06 Thousand | -21.08 Thousand | -18.47 Thousand |
| Net cash flow / Change in cash | -4.79 Million | -8.15 Million | 10.47 Million | -10.39 Million | 2.56 Million | 1.84 Million |
| Free Cash Flow | -5.15 Million | -10.62 Million | -2.1 Million | 1.92 Million | 2 Million | 286.38 Thousand |
MRT
ACHKF
ADK
603223
4385
OPINL